Bio Green Med Solution Statistics
Total Valuation
BGMS has a market cap or net worth of $6.02 million. The enterprise value is $2.68 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BGMS has 5.52 million shares outstanding. The number of shares has increased by 300.32% in one year.
| Current Share Class | 5.52M |
| Shares Outstanding | 5.52M |
| Shares Change (YoY) | +300.32% |
| Shares Change (QoQ) | +18.49% |
| Owned by Insiders (%) | 32.24% |
| Owned by Institutions (%) | 2.15% |
| Float | 3.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.95 |
| Forward PS | n/a |
| PB Ratio | 0.88 |
| P/TBV Ratio | 1.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.06
| Current Ratio | 7.06 |
| Quick Ratio | 5.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 20.59% and return on invested capital (ROIC) is -126.93%.
| Return on Equity (ROE) | 20.59% |
| Return on Assets (ROA) | -49.33% |
| Return on Invested Capital (ROIC) | -126.93% |
| Return on Capital Employed (ROCE) | -65.88% |
| Weighted Average Cost of Capital (WACC) | 1.62% |
| Revenue Per Employee | $127,083 |
| Profits Per Employee | -$1.19M |
| Employee Count | 12 |
| Asset Turnover | 0.27 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BGMS has paid $37,000 in taxes.
| Income Tax | 37,000 |
| Effective Tax Rate | 3.53% |
Stock Price Statistics
The stock price has decreased by -95.54% in the last 52 weeks. The beta is -0.48, so BGMS's price volatility has been lower than the market average.
| Beta (5Y) | -0.48 |
| 52-Week Price Change | -95.54% |
| 50-Day Moving Average | 1.01 |
| 200-Day Moving Average | 2.31 |
| Relative Strength Index (RSI) | 59.71 |
| Average Volume (20 Days) | 27,781 |
Short Selling Information
The latest short interest is 26,327, so 0.48% of the outstanding shares have been sold short.
| Short Interest | 26,327 |
| Short Previous Month | 36,638 |
| Short % of Shares Out | 0.48% |
| Short % of Float | 0.76% |
| Short Ratio (days to cover) | 0.36 |
Income Statement
In the last 12 months, BGMS had revenue of $1.53 million and -$14.23 million in losses. Loss per share was -$4.11.
| Revenue | 1.53M |
| Gross Profit | -530,000 |
| Operating Income | -4.46M |
| Pretax Income | 1.05M |
| Net Income | -14.23M |
| EBITDA | -4.45M |
| EBIT | -4.46M |
| Loss Per Share | -$4.11 |
Full Income Statement Balance Sheet
The company has $3.34 million in cash and n/a in debt, with a net cash position of $3.34 million or $0.60 per share.
| Cash & Cash Equivalents | 3.34M |
| Total Debt | n/a |
| Net Cash | 3.34M |
| Net Cash Per Share | $0.60 |
| Equity (Book Value) | 6.76M |
| Book Value Per Share | 1.24 |
| Working Capital | 4.83M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 4,750 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is -34.75%, with operating and profit margins of -292.39% and -204.20%.
| Gross Margin | -34.75% |
| Operating Margin | -292.39% |
| Pretax Margin | 68.72% |
| Profit Margin | -204.20% |
| EBITDA Margin | -292.08% |
| EBIT Margin | -292.39% |
| FCF Margin | n/a |